Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Fallon Insider Profile
4 Followers
John Fallon, Director at Insulet, holds 47.15K shares in Collegium Pharmaceutical (Ticker: COLL), holds 14.50K shares in Insulet (Ticker: PODD), holds 0.00 shares in Amag Pharmaceuticals (Ticker: AMAG).
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-9.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Fallon holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Fallon
John Fallon's Trading History
Insulet
May 25, 2021
Director
Informative Sell
1.48M
$2.43M
Exact Sciences
Aug 01, 2018
Director
Uninformative Sell
139.67K
$2.15M
Collegium Pharmaceutical
May 19, 2023
Director
Uninformative Buy
―
$1.69M
Amag Pharmaceuticals
Nov 17, 2020
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see John Fallon's performance on stock
You May Also Like
John Fallon insider profile FAQ
What is the percentage of profitable transactions made by John Fallon?
The percentage of profitable transactions made by John Fallon is 40%.
What is the average return per transaction made by John Fallon?
The average return per transaction made by John Fallon is -9.90%.
What stocks does John Fallon hold?
John Fallon holds: PODD, EXAS, COLL, AMAG stocks.
What was John Fallon’s latest transaction?
John Fallon latest transaction was an Uninformative Buy of ―.
What was John Fallon's most profitable transaction?
John Fallon’s most profitable transaction was an Informative Sell of PODD stock on May 25, 2021. The return on the trade was 14.60%.
What is John Fallon's role in Insulet?
John Fallon's role in Insulet is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.